| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$5,571 ) |
| | 2023 | 2020 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 000 | 3 | NIH | 3/16/2023 | -$5,571 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43MH118186 | Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging | 000 | 1 | NIH | 4/29/2021 | $0 |
| | 2021 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 3 | NIH | 7/2/2021 | $0 |
| | 2021 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R42GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicine | 000 | 3 | NIH | 5/30/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $491,375 ) |
| | 2020 | 2020 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 001 | 3 | NIH | 6/23/2020 | $0 |
| | 2020 | 2020 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 000 | 3 | NIH | 6/17/2020 | $491,375 |
| | 2020 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43MH118186 | Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging | 000 | 1 | NIH | 7/2/2020 | $0 |
| | 2020 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R42GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicine | 000 | 3 | NIH | 7/15/2020 | $0 |
| | 2020 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 3 | NIH | 8/12/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $499,634 ) |
| | 2019 | 2019 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 000 | 2 | NIH | 7/2/2019 | $499,634 |
| | 2019 | 2016 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44ES022567 | Expressing bacterial bioluminescence in human cell lines: Engineering autobioluminescent reporter cells to screen for endocrine disruptor chemicals | 000 | 3 | NIH | 11/16/2018 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $1,121,651 ) |
| | 2018 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43MH118186 | Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging | 000 | 1 | NIH | 6/26/2018 | $150,000 |
| | 2018 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43MH118186 | Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging | 001 | 1 | NIH | 9/6/2018 | -$150,000 |
| | 2018 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43MH118186 | Autonomously-activating bioluminescent reporters to enable continuous, real-time, non-invasive brain cell imaging | 001 | 1 | NIH | 9/6/2018 | $150,000 |
| | 2018 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R42GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicine | 000 | 3 | NIH | 8/22/2018 | $497,759 |
| | 2018 | 2018 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 3 | NIH | 8/21/2018 | $473,892 |
| | 2018 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 000 | 1 | NIH | 10/30/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,018,818 ) |
| | 2017 | 2017 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R42GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond fireflyluciferase to expand the informational capacity of animal models for regenerativemedicine | 000 | 2 | NIH | 9/1/2017 | $496,198 |
| | 2017 | 2017 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R44GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 2 | NIH | 9/20/2017 | $522,620 |
| | 2017 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R43GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 1 | NIH | 1/4/2017 | $0 |
| | 2017 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DR | KNOXVILLE | TN | 37996-0001 | KNOX | USA | R41GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond firefly luciferase to expand the informational capacity of animal models for regenerative medicine | 000 | 1 | NIH | 4/7/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $457,746 ) |
| | 2016 | 2016 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R44ES022567 | Expressing bacterial bioluminescence in human cell lines: Engineering autobioluminescent reporter cells to screen for endocrine disruptor chemicals | 000 | 3 | NIH | 6/20/2016 | $457,746 |
|
| Issue Date FY: 2015 ( Subtotal = $1,061,942 ) |
| | 2015 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R43ES026269 | Expanding the throughput of real-time toxicological screening of cardiac differentiation by expressing a synthetic luciferase/luciferin genetic pathway in iPSCs | 000 | 1 | NIH | 8/13/2015 | $224,924 |
| | 2015 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R43GM112241 | Development of a high-throughput screen to detect the effects of both pre- and post-biotransformed compounds for enhanced content drug discovery workflows | 000 | 1 | NIH | 6/29/2015 | $149,051 |
| | 2015 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R44ES022567 | Expressing bacterial bioluminescence in human cell lines: Engineering autobioluminescent reporter cells to screen for endocrine disruptor chemicals | 000 | 2 | NIH | 7/13/2015 | $538,007 |
| | 2015 | 2015 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R41GM116622 | Expressing humanized bacterial luciferase in stem cells: Moving beyond firefly luciferase to expand the informational capacity of animal models for regenerative medicine | 000 | 1 | NIH | 7/13/2015 | $149,960 |
|
| Issue Date FY: 2013 ( Subtotal = $138,191 ) |
| | 2013 | 2013 | 490 BIOTECH INC | 2450 EJ CHAPMAN DRIVE | KNOXVILLE | TN | 37996 | KNOX | USA | R43ES022567 | EXPRESSING BACTERIAL BIOLUMINESCENCE IN HUMAN CELL LINES: ENGINEERING AUTOBIOLUMI | 000 | 1 | NIH | 2/18/2013 | $138,191 |
|
|
